Vincristine and bortezomib use distinct upstream mechanisms to activate a common SARM1-dependent axon degeneration program (Q93105631)
Jump to navigation
Jump to search
scientific article published on 05 September 2019
Language | Label | Description | Also known as |
---|---|---|---|
English | Vincristine and bortezomib use distinct upstream mechanisms to activate a common SARM1-dependent axon degeneration program |
scientific article published on 05 September 2019 |
Statements
Vincristine and bortezomib use distinct upstream mechanisms to activate a common SARM1-dependent axon degeneration program (English)
Ryan A Doan
Aysel Cetinkaya-Fisgin
Shay X Huang